# A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

> **NCT00907608** · NA · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00907608
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Due to difficulty in patient recruitment
- **Last updated:** 2009-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907608, "A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00907608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*